The IPO Buzz: Biotechs Jump-Start 2022
Biotechs braved the chill winds of January to jump-start the 2022 IPO Calendar. Two of the week’s three biotech IPOs – Amylyx Pharmaceuticals (AMLX) and CinCor Pharma (CINC) – upsized their IPOs by adding more shares and pricing their deals at the mid-point of their ranges. The third biotech IPO – Vigil Neuroscience, Inc. (VIGL) – […]
January 7, 2022 Read More